Suzumiya, J., Ohshima, K., Tamura, K., Karube, K., Uike, N., Tobinai, K., ...
Background: The International Peripheral T-cell Lymphoma Project was organized to better understand the T-cell and natural killer (NK) cell lymphomas, and our task is to present the clinicopathologic...
Itoh, K., Ohtsu, T., Fukuda, H., Sasaki, Y., Ogura, M., Morishima, Y., ...
Background: CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone) is accepted as the best available standard treatment for first-line chemotherapy in aggressive non-Hodgkin’s lymphoma...
Igarashi, T., Kobayashi, Y., Ogura, M., Kinoshita, T., Ohtsu, T., Sasaki, Y., ...
Background The aim of the study was to determine factors affecting the toxicity and efficacy of rituximab monotherapy in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma...
Interleukin 4 suppresses the spontaneous growth of chronic myelomonocytic leukemia cells.
Akashi, K, Shibuya, T, Harada, M, Takamatsu, Y, Uike, N, Eto, T, ...
We studied the effects of IL-4 on the spontaneous proliferation of chronic myelomonocytic leukemia (CMMoL) cells in vitro. IL-4 (100 U/ml) suppressed the spontaneous DNA synthesis by approximately...
Interleukin 4 suppresses the spontaneous growth of chronic myelomonocytic leukemia cells.
Akashi, K, Shibuya, T, Harada, M, Takamatsu, Y, Uike, N, Eto, T, ...
We studied the effects of IL-4 on the spontaneous proliferation of chronic myelomonocytic leukemia (CMMoL) cells in vitro. IL-4 (100 U/ml) suppressed the spontaneous DNA synthesis by approximately...